Hydroxyapatite Coated VESTASync Cardiac Stents

MIV Therapeutics, an Atlanta, Georgia firm, isundergoing trials of its biocompatible polymer-free coating technologyfor cardiac stents, a platform designed to prevent adverse reactions tothe metal stents and prevent tissue regrowth around the implant.

Source: medgadget.comAdded: 6 June 2008